Thomas Müller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thomas Müller has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alexandros Rahn
Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
5 shared publications - Doris Franke
Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany
3 shared publications - Lara Klischke
Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
3 shared publications - Sabine Pirr
Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
3 shared publications - Bettina Bohnhorst
Department of pediatric Pneumology, Allergology and Neonatology Hannover Medical School Hannover Germany
2 shared publications - Carolin Böhne
Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 898
Organ size in small infants (The OSSI Study): are sonographic reference intervals applicable in preterm infants small for gestational age?
Sonographic reference intervals for liver, spleen, and kidney size in preterm infants below 40 cm body length were recently established in an appropriately grown (AGA) neonatal cohort. Whether these intervals apply to infants born small for gestational age (SGA) remains unexamined. In this cross-sectional study, 20 preterm SGA infants below 40 cm body length (mean gestational age 29 1 / 7 weeks, median birth weight 695 g) underwent standardized abdominal ultrasound, measuring craniocaudal liver length in three planes, splenic length, and renal volume. Measurements were compared with published reference intervals, and z-scores assessed systematic deviation. Weight and length at examination were comparable between the SGA and AGA cohorts. The mean z-score was significantly below zero only for liver length in the midclavicular line (− 0.79, p = 0.014). The proportion of infants outside the reference interval exceeded the expected 5% for liver length in the midclavicular line (25%, p = 0.003) and anterior axillary line (20%, p = 0.016) and for spleen length (20%, p = 0.016), but rested on 4 to 5 infants each, and several values lay within 1 mm of the limit. Kidney measurements did not differ from the reference. Organ size correlated most strongly with body weight, and the deviations persisted at equal weight (post hoc). Conclusion : Abdominal organ dimensions in SGA preterm infants frequently fall outside AGA-derived reference intervals, particularly for liver and spleen size, suggesting that these intervals cannot be reliably applied to this population. Prospective studies establishing reference values for SGA infants are warranted. What is Known: • Sonographic reference intervals for abdominal organ size in preterm infants below 40 cm exist only for appropriately grown (AGA) infants; their applicability to infants small for gestational age (SGA) has not been examined . What is New: • In 20 preterm SGA infants, the mean z-score for liver length (midclavicular line) was below the AGA reference, and liver and spleen lengths fell outside the intervals more often than the expected 5% (exploratory) . • AGA intervals should not be assumed to apply to SGA infants .
- 28 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 898
Open AccessOrgan size in small infants (The OSSI Study): are sonographic reference intervals applicable in preterm infants small for gestational age?
Sonographic reference intervals for liver, spleen, and kidney size in preterm infants below 40 cm body length were recently established in an appropriately grown (AGA) neonatal cohort. Whether these intervals apply to infants born small for gestational age (SGA) remains unexamined. In this cross-sectional study, 20 preterm SGA infants below 40 cm body length (mean gestational age 29 1 / 7 weeks, median birth weight 695 g) underwent standardized abdominal ultrasound, measuring craniocaudal liver length in three planes, splenic length, and renal volume. Measurements were compared with published reference intervals, and z-scores assessed systematic deviation. Weight and length at examination were comparable between the SGA and AGA cohorts. The mean z-score was significantly below zero only for liver length in the midclavicular line (− 0.79, p = 0.014). The proportion of infants outside the reference interval exceeded the expected 5% for liver length in the midclavicular line (25%, p = 0.003) and anterior axillary line (20%, p = 0.016) and for spleen length (20%, p = 0.016), but rested on 4 to 5 infants each, and several values lay within 1 mm of the limit. Kidney measurements did not differ from the reference. Organ size correlated most strongly with body weight, and the deviations persisted at equal weight (post hoc). Conclusion : Abdominal organ dimensions in SGA preterm infants frequently fall outside AGA-derived reference intervals, particularly for liver and spleen size, suggesting that these intervals cannot be reliably applied to this population. Prospective studies establishing reference values for SGA infants are warranted. What is Known: • Sonographic reference intervals for abdominal organ size in preterm infants below 40 cm exist only for appropriately grown (AGA) infants; their applicability to infants small for gestational age (SGA) has not been examined . What is New: • In 20 preterm SGA infants, the mean z-score for liver length (midclavicular line) was below the AGA reference, and liver and spleen lengths fell outside the intervals more often than the expected 5% (exploratory) . • AGA intervals should not be assumed to apply to SGA infants .
- Open Access
- 30 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (7)
Bubbles in the barely born—contrast-enhanced ultrasound in neonates: a single-center experience
To assess clinical value, safety, and applicability of contrast-enhanced ultrasound (CEUS) in neonates, focusing on bedside use in intensive care. This retrospective single-center study included 23 neonates undergoing intravenous CEUS between 2010 and 2024, including seven preterm infants. The liver ( n = 18) was the most frequently examined organ, followed by kidneys ( n = 2), brain ( n = 2), and adrenals ( n = 1). Findings were compared with MRI ( n = 10), CT ( n = 3), or biopsy ( n = 8), when available. In nine cases, CEUS findings were consistent with clinical course and treatment response only, without an independent reference standard. Among the 14 cases with available reference diagnostics, CEUS established the diagnosis first in ten (71.4%); histological confirmation was available in eight cases, with concordance in five (62.5%). 13 examinations (56.5%) were performed for bedside problem-solving in the neonatal intensive care unit, and no adverse events were observed. Conclusion : CEUS provided clinically relevant diagnostic information in neonates, including preterm and critically ill infants and was well tolerated. CEUS was particularly valuable in hepatic vascular tumors, where it could provide a definite diagnosis, enabled hemodynamic assessment, supported treatment decisions, and aided identification of potentially life-threatening complications. Bedside use enabled timely diagnosis without sedation, intubation, or patient transport, thereby supporting minimal handling. In selected cases, CEUS may reduce the need for cross-sectional imaging. Despite off-label use, our findings suggest a beneficial role for CEUS in neonatal imaging, predominantly for hepatic indications. What is Known: • Contrast-enhanced ultrasound (CEUS) is a radiation-free, bedside-compatible imaging technique with an established safety profile in pediatric patients. • Neonatal CEUS experience is limited to small case series, predominantly reporting cerebral applications. What is New: • CEUS was feasible and well tolerated in neonates including preterm infants, with no adverse events in 23 examinations. • CEUS yielded clinically relevant diagnostic information across a range of indications, primarily hepatic, encompassing both focal lesions and perfusion assessment, supporting clinical decision-making in neonatal care.
- 30 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (7)
Open AccessBubbles in the barely born—contrast-enhanced ultrasound in neonates: a single-center experience
To assess clinical value, safety, and applicability of contrast-enhanced ultrasound (CEUS) in neonates, focusing on bedside use in intensive care. This retrospective single-center study included 23 neonates undergoing intravenous CEUS between 2010 and 2024, including seven preterm infants. The liver ( n = 18) was the most frequently examined organ, followed by kidneys ( n = 2), brain ( n = 2), and adrenals ( n = 1). Findings were compared with MRI ( n = 10), CT ( n = 3), or biopsy ( n = 8), when available. In nine cases, CEUS findings were consistent with clinical course and treatment response only, without an independent reference standard. Among the 14 cases with available reference diagnostics, CEUS established the diagnosis first in ten (71.4%); histological confirmation was available in eight cases, with concordance in five (62.5%). 13 examinations (56.5%) were performed for bedside problem-solving in the neonatal intensive care unit, and no adverse events were observed. Conclusion : CEUS provided clinically relevant diagnostic information in neonates, including preterm and critically ill infants and was well tolerated. CEUS was particularly valuable in hepatic vascular tumors, where it could provide a definite diagnosis, enabled hemodynamic assessment, supported treatment decisions, and aided identification of potentially life-threatening complications. Bedside use enabled timely diagnosis without sedation, intubation, or patient transport, thereby supporting minimal handling. In selected cases, CEUS may reduce the need for cross-sectional imaging. Despite off-label use, our findings suggest a beneficial role for CEUS in neonatal imaging, predominantly for hepatic indications. What is Known: • Contrast-enhanced ultrasound (CEUS) is a radiation-free, bedside-compatible imaging technique with an established safety profile in pediatric patients. • Neonatal CEUS experience is limited to small case series, predominantly reporting cerebral applications. What is New: • CEUS was feasible and well tolerated in neonates including preterm infants, with no adverse events in 23 examinations. • CEUS yielded clinically relevant diagnostic information across a range of indications, primarily hepatic, encompassing both focal lesions and perfusion assessment, supporting clinical decision-making in neonatal care.
- Open Access
- 28 May 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6)
Organ size in small infants (The OSSI Study): establishing sonographic reference intervals for abdominal organs in preterm infants
Accurate ultrasound assessment of abdominal organ size in preterm infants is essential for evaluating growth and detecting abnormalities. However, standardized reference intervals for liver, spleen, and kidney dimensions in preterms below 40 cm body length are lacking. This study aimed to establish reference intervals for these organs. 57 eutrophic preterm infants with a body length below 40 cm (gestational age: 23 4 / 7 —31 5 / 7 weeks; birth length: 29—39.5 cm) were prospectively examined using a standardized ultrasound protocol recommended by the German Society for Ultrasound in Medicine (DEGUM). Craniocaudal liver length, spleen length, and renal volume were measured and correlated with corrected gestational age, body weight, and body length. Reference intervals were calculated from log-transformed data with 95% confidence intervals for reference limits. Portal vein peak velocity before feeding and presence of a patent ductus venosus (PDV) were additionally assessed. Organ dimensions correlated most closely with body weight, followed by body length and corrected gestational age, with renal volume showing the highest correlations overall. Reference intervals for liver, spleen, and renal size showed tight 95% confidence intervals. Portal vein peak velocity ranged from 9—29 cm/s. A PDV was present in 56%; these infants were younger at examination (10.9 vs. 17 days, p = 0.01). Conclusion : This study provides clinically relevant ultrasound reference intervals for abdominal organs in small preterm infants. These measurements may help distinguish physiological from pathological findings and guide clinical decision-making in neonatal care. What is Known: • Ultrasound is the preferred imaging modality for abdominal organ assessment in preterm infants, but standardized sonographic reference intervals for infants with a body length below 40 cm are lacking. What is New: • This study provides the first standardized sonographic reference intervals for liver length, splenic length, and renal volume in preterm infants below 40 cm body length, using a prospective, reproducible protocol aligned with DEGUM recommendations. • Organ size correlated most strongly with body weight, followed by body length and corrected gestational age, with renal volume showing the highest overall correlations across all parameters.
- 28 May 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6)
Open AccessOrgan size in small infants (The OSSI Study): establishing sonographic reference intervals for abdominal organs in preterm infants
Accurate ultrasound assessment of abdominal organ size in preterm infants is essential for evaluating growth and detecting abnormalities. However, standardized reference intervals for liver, spleen, and kidney dimensions in preterms below 40 cm body length are lacking. This study aimed to establish reference intervals for these organs. 57 eutrophic preterm infants with a body length below 40 cm (gestational age: 23 4 / 7 —31 5 / 7 weeks; birth length: 29—39.5 cm) were prospectively examined using a standardized ultrasound protocol recommended by the German Society for Ultrasound in Medicine (DEGUM). Craniocaudal liver length, spleen length, and renal volume were measured and correlated with corrected gestational age, body weight, and body length. Reference intervals were calculated from log-transformed data with 95% confidence intervals for reference limits. Portal vein peak velocity before feeding and presence of a patent ductus venosus (PDV) were additionally assessed. Organ dimensions correlated most closely with body weight, followed by body length and corrected gestational age, with renal volume showing the highest correlations overall. Reference intervals for liver, spleen, and renal size showed tight 95% confidence intervals. Portal vein peak velocity ranged from 9—29 cm/s. A PDV was present in 56%; these infants were younger at examination (10.9 vs. 17 days, p = 0.01). Conclusion : This study provides clinically relevant ultrasound reference intervals for abdominal organs in small preterm infants. These measurements may help distinguish physiological from pathological findings and guide clinical decision-making in neonatal care. What is Known: • Ultrasound is the preferred imaging modality for abdominal organ assessment in preterm infants, but standardized sonographic reference intervals for infants with a body length below 40 cm are lacking. What is New: • This study provides the first standardized sonographic reference intervals for liver length, splenic length, and renal volume in preterm infants below 40 cm body length, using a prospective, reproducible protocol aligned with DEGUM recommendations. • Organ size correlated most strongly with body weight, followed by body length and corrected gestational age, with renal volume showing the highest overall correlations across all parameters.
- Open Access
- 18 May 2026
- Published by Wiley in Acta Paediatrica
- Vol. 115 (9) , 1982-1990
Doxapram Exposure Was Not Associated With Adverse Neurodevelopmental Outcomes in Very Low Birth Weight Infants: A Monocentric Retrospective Cohort Study
Aim: Doxapram is used as an additional therapy for apnea of prematurity when standard treatments such as caffeine or continuous positive airway pressure are insufficient, but its impact on long‐term neurodevelopment remains uncertain. This study evaluated the association between Doxapram exposure and neurodevelopmental outcomes in very low birth weight infants (VLBWI), with a focus on potential dose‐dependent effects. Methods: In this monocentric retrospective cohort study, VLBWI with gestational age ≤ 32 weeks were included. Infants treated with Doxapram ( n = 140) were compared to untreated controls ( n = 280) matched by year of birth. Exposure was stratified by cumulative dose. The primary outcome was neurodevelopment at 24 months corrected age assessed by the mental development index or global development quotient (MDI/GDQ). Secondary outcomes included mortality, growth parameters and neurological outcomes. Multivariable logistic regression adjusted for confounders. Results: Neurodevelopment did not differ between groups (MDI/GDQ: 94.2 ± 21.2 vs. 97.7 ± 14.8; p = 0.1), nor did mortality (5.0% vs. 6.8%; p = 0.53). No dose‐dependent associations were observed. Secondary outcomes were comparable. Conclusions: Doxapram exposure was not associated with adverse neurodevelopmental outcomes in VLBWI within the investigated dosage range, although definitive conclusions on drug safety cannot be drawn from medium‐sized cohorts and confirmation in prospective randomised studies is required.
- 18 May 2026
- Published by Wiley in Acta Paediatrica
- Vol. 115 (9) , 1982-1990
Open AccessDoxapram Exposure Was Not Associated With Adverse Neurodevelopmental Outcomes in Very Low Birth Weight Infants: A Monocentric Retrospective Cohort Study
Aim: Doxapram is used as an additional therapy for apnea of prematurity when standard treatments such as caffeine or continuous positive airway pressure are insufficient, but its impact on long‐term neurodevelopment remains uncertain. This study evaluated the association between Doxapram exposure and neurodevelopmental outcomes in very low birth weight infants (VLBWI), with a focus on potential dose‐dependent effects. Methods: In this monocentric retrospective cohort study, VLBWI with gestational age ≤ 32 weeks were included. Infants treated with Doxapram ( n = 140) were compared to untreated controls ( n = 280) matched by year of birth. Exposure was stratified by cumulative dose. The primary outcome was neurodevelopment at 24 months corrected age assessed by the mental development index or global development quotient (MDI/GDQ). Secondary outcomes included mortality, growth parameters and neurological outcomes. Multivariable logistic regression adjusted for confounders. Results: Neurodevelopment did not differ between groups (MDI/GDQ: 94.2 ± 21.2 vs. 97.7 ± 14.8; p = 0.1), nor did mortality (5.0% vs. 6.8%; p = 0.53). No dose‐dependent associations were observed. Secondary outcomes were comparable. Conclusions: Doxapram exposure was not associated with adverse neurodevelopmental outcomes in VLBWI within the investigated dosage range, although definitive conclusions on drug safety cannot be drawn from medium‐sized cohorts and confirmation in prospective randomised studies is required.
- Open Access
- 11 June 2025
- Published by Elsevier in Journal of Neonatal Nursing
- Vol. 31 (4)
Scans, stress, and solutions: The influence of ultrasound examinations on the daily work of nursing staff in a level III neonatal intensive care unit
- 11 June 2025
- Published by Elsevier in Journal of Neonatal Nursing
- Vol. 31 (4)
Open AccessScans, stress, and solutions: The influence of ultrasound examinations on the daily work of nursing staff in a level III neonatal intensive care unit